River BioMedics was featured as one of the inventions emerging from the University of Twente. Read more in the interview with our Scientific Advisory Board member Prof. Albert van den Berg, in the local newspaper Tubantia!Read More
In an interview with the local newspaper Tubantia, we explain how we are building our 3D cardiac models and why our high-throughput technology is crucial to perform large drug screens for pharmaceutical companies.Read More
Tom is joining River BioMedics as an assistent scientist, specialised in microfluidics and organ-on-chip. He will be working on the development of River BioMedic’s high-throughput platform. Happy to have him on board!Read More
River BioMedics was featured in “Nederland maakt het” a Dutch television show about innovative companies in The Netherlands. Watch our item below to hear more about what we do to improve cardiac drug discovery!Read More
Together with researchers from the Leiden University Medical center and the University of Twente, and in collaboration with NCardia we are going to develop a heart-on-chip model to determine the effects of a COVID19 infection and of COVID19 pharmacotherapies on the heart. For this project we received funding from Health~Holland.Read More
Together with IamFluidics, Scinus Cell Expansion and the University of Twente, we received a €1 million subsidy from EFRO (Europees Fonds voor Regionale Ontwikkeling) OP Oost, in order to develop an efficient method of culturing human induced pluripotent stem cells (hiPSC) using microcarriers. We are proud to be part of this innovative initiative!Read More
We are ready for Take-off! 🚀Today we received the €250,000 Take-off phase 2 subsidy from NWO (Dutch Research Council) to accelerate our product development.Read More
We are delighted to announce that River BioMedics closed a successful deal with the University of Twente to spin-off! We are grateful for the collaboration and outstanding support of the University of Twente and especially the Novel-T team.Read More
We are very excited to participate in the LIP@HEART project granted by Health~Holland to develop a heart-on-chip model using our 3D cardiac platform to facilitate identification of lipoprotein lipase-activating compounds! Result of a great collaboration with the Leiden University Medical Center and University of Twente.Read More
